Fri, October 13, 2023
Thu, October 12, 2023
Wed, October 11, 2023
Tue, October 10, 2023
Mon, October 9, 2023

Christopher Raymond Maintained (ALXO) at Buy with Increased Target to $11 on, Oct 11th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-11-on-oct-11th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Christopher Raymond of Piper Sandler, Maintained "ALX Oncology Holdings Inc." (ALXO) at Buy with Increased Target from $8 to $11 on, Oct 11th, 2023.

Christopher has made no other calls on ALXO in the last 4 months.



There are 4 other peers that have a rating on ALXO. Out of the 4 peers that are also analyzing ALXO, 0 agree with Christopher's Rating of Hold.



These are the ratings of the 4 analyists that currently disagree with Christopher


  • Colin Bristow of "UBS" Maintained at Strong Buy with Decreased Target to $27 on, Wednesday, October 4th, 2023
  • Li Watsek of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $23 on, Wednesday, October 4th, 2023
  • Swayampakula Ramakanth of "HC Wainwright & Co." Reiterated at Strong Buy with Increased Target to $18 on, Tuesday, October 3rd, 2023
  • Alethia Young of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $18 on, Tuesday, September 12th, 2023

Publication Contributing Sources